Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy.

Nano letters·2026
Same author

Injectable gelatin-PEG hydrogels obtained <i>via</i> cytochrome C-mediated polymerization.

Organic & biomolecular chemistry·2026
Same author

Questing for Integrin Targeting Theranostics for Cancer Cell-Selective Molecules.

ACS omega·2026
Same author

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).

European journal of cancer (Oxford, England : 1990)·2026
Same author

Stimuli-Responsive Silsesquioxane Nanozymes for Organocatalysis in Water and Prodrug Activation in Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Cross-Linking PEG Microgels with Mesoporous Organosilica Nanoparticles to Engineer Microporous Annealed Particle Scaffold Properties.

ACS omega·2026

Related Experiment Video

Updated: Aug 7, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.1K

Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli-Responsive Nanocages.

María Sancho-Albero1, Giorgio Facchetti2, Nicolò Panini3

  • 1Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, 20156, Italy.

Advanced Healthcare Materials
|March 13, 2023
PubMed
Summary

A novel platinum(IV) prodrug, stabilized within a breakable nanocarrier, effectively targets and releases chemotherapy agents within cancer cells. This approach shows promise for treating platinum-resistant cancers like malignant pleural mesothelioma.

Keywords:
mesotheliomananocagesorganosilicaplatinum complexestumor reduction

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.7K

Related Experiment Videos

Last Updated: Aug 7, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.1K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.7K

Area of Science:

  • Nanotechnology
  • Oncology
  • Materials Science

Background:

  • Platinum-based chemotherapy is a standard first-line treatment for various cancers.
  • Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer with limited treatment options.
  • Drug delivery systems are crucial for improving the efficacy and reducing the side effects of chemotherapy.

Purpose of the Study:

  • To develop a novel nanocarrier system for stabilizing and delivering a platinum(IV) prodrug.
  • To investigate the intracellular release and activation mechanism of the platinum(IV) prodrug within cancer cells.
  • To evaluate the in vitro and in vivo efficacy of the platinum(IV) prodrug-loaded nanocarrier against malignant pleural mesothelioma.

Main Methods:

  • Encapsulation of a hydrophobic platinum(IV) complex within a breakable nanocage.
  • In vitro evaluation of cellular uptake, internalization kinetics, and drug release using flow cytometry.
  • In vivo efficacy studies using a patient-derived malignant pleural mesothelioma xenograft mouse model.

Main Results:

  • The nanocarrier successfully stabilized and delivered the platinum(IV) prodrug into cancer cells.
  • Glutathione in cancer cells promoted prodrug reduction and nanocarrier destruction, leading to intracellular drug activation.
  • In vivo studies demonstrated a 50% reduction in tumor growth for malignant pleural mesothelioma in mice treated with the Pt(IV) prodrug-loaded nanocarrier.

Conclusions:

  • The developed nanocarrier system offers a promising strategy for the targeted delivery and activation of platinum(IV) prodrugs.
  • This approach overcomes cisplatin resistance in malignant pleural mesothelioma, showing significant tumor growth inhibition.
  • The study highlights the potential of nanotechnology-based drug delivery for improving cancer therapy.